Guardian Pharmacy Services, Inc. Stock Price, News & Analysis

Guardian Pharmacy Services (NYSE: GRDN) has announced the pricing of its underwritten public offering of 7.5 million shares of Class A common stock at $21.00 per share. The offering consists of 6,059,553 shares from selling stockholders and 1,440,447 shares from Guardian in a non-dilutive synthetic secondary transaction. The underwriters have a 30-day option to purchase an additional 1,125,000 shares.

The offering, expected to close on May 27, 2025, is structured as non-dilutive since Guardian will use all net proceeds to repurchase 1,440,447 shares of Class A common stock at the offering price less underwriting discount. The total number of outstanding shares will remain unchanged after completion. Raymond James leads the offering as bookrunning manager, with Stephens Inc. and Truist Securities as joint bookrunning managers.

Guardian Pharmacy Services (NYSE: GRDN) has announced a proposed underwritten public offering of 7.5 million shares of Class A common stock. The offering consists of 6,059,553 shares from selling stockholders and 1,440,447 newly issued shares from Guardian. The underwriters will have a 30-day option to purchase an additional 1,125,000 shares.

The offering is structured as a non-dilutive "synthetic secondary" transaction, where Guardian will use all net proceeds to repurchase an equal number of Class A shares from certain stockholders at the public offering price less underwriting discount. This ensures the total outstanding shares remain unchanged. Raymond James leads the offering as bookrunning manager, with Stephens Inc. and Truist Securities acting as joint bookrunning managers.

Guardian Pharmacy Services (NYSE: GRDN) has announced the acquisition of Senior Care Pharmacy in Wichita, Kansas, expanding its long-term care (LTC) pharmacy services footprint in the Midwest. The acquisition strengthens Guardian's presence in south central and southwest Kansas, marking its second pharmacy location in the state alongside its Kansas City operation.

The Wichita location will maintain its existing name, leadership team, and staff, with Michael Counts, president of Guardian's Kansas City pharmacy, overseeing both locations. The acquired pharmacy will benefit from Guardian's local management business model and centralized Corporate Support Team services, including data analytics, HR, IT, and payor relations.

Founded in 2004, Guardian has grown to 52 pharmacies across 38 states through organic expansion, greenfield startups, and acquisitions.

Guardian Pharmacy Services (NYSE: GRDN) reported strong Q1 2025 financial results, with revenue reaching $329.3 million, up 20% year-over-year. The company's resident count increased 15% to 189,000, while net income grew by $2.2 million to $9.3 million. Adjusted EBITDA rose 16% to $23.4 million.

The growth was driven by organic expansion and recent acquisitions, including Heartland Pharmacy and Freedom Pharmacy. Guardian completed another acquisition in Wichita, Kansas on April 1, 2025, bringing its total pharmacy count to 52. The company maintains a strong financial position with $14.0 million in cash and no long-term debt.

Guardian reaffirmed its 2025 guidance, expecting revenue between $1.330-1.350 billion and Adjusted EBITDA of $97-101 million.

Guardian Pharmacy Services (NYSE: GRDN), a leading long-term care pharmacy services provider, has appointed Ashley Stockton as Senior Director, Head of Investor Relations. Stockton brings nearly 30 years of equity markets experience, most recently serving as Head of Southeast Institutional Equity Sales at J.P. Morgan. Her background includes roles in equity research and investment banking.

In her new position, Stockton will lead investor relations strategy and act as the primary liaison with shareholders, analysts, and the investment community. CEO Fred Burke highlighted her extensive background in equity markets and experience advising institutional investors as key qualifications for the role. Stockton holds a BS from the University of Virginia's McIntire School of Commerce and serves on the Georgia Securities Association board.

Guardian Pharmacy Services (NYSE: GRDN), a leading long-term care (LTC) pharmacy services provider in the United States, has scheduled its first quarter 2025 financial results announcement for Monday, May 12, 2025, after market close.

The company will host a conference call at 4:30 pm ET to discuss the quarterly results. Investors and analysts can access the call through:

• Audio webcast: https://investors.guardianpharmacy.com
• U.S. participants dial-in: (646) 564-2877
• International participants dial-in: +1 (800) 549-8228
• Conference ID: "96083"

A replay of the call will be made available shortly after completion and will remain accessible for approximately 60 days.

Guardian Pharmacy Services (NYSE: GRDN) has announced the opening of a new pharmacy location in Columbus, Ohio, expanding its long-term care (LTC) pharmacy services across Ohio, Kentucky, and West Virginia. The new facility, operating as Guardian Pharmacy of Ohio, complements the existing Mullaney's Pharmacy operation in Cincinnati.

The 5,600-square-foot Columbus facility features state-of-the-art technology, automation, and a training center. Since joining Guardian in 2020, Mullaney's Pharmacy has tripled its resident service numbers in less than five years. Tom Mullaney, RPh, will lead both locations alongside Director of Operations Troy Stinson and Joshua Heiden as pharmacist-in-charge.

The expansion strengthens Guardian's presence in the region, serving assisted living, skilled nursing, behavioral health communities, and individuals with intellectual and developmental disabilities. Guardian Pharmacy Services has grown from a single location to 51 pharmacies across 38 states since its founding in 2004.

Guardian Pharmacy Services (NYSE: GRDN) has announced the opening of a new pharmacy in Naples, Florida, expanding its long-term care (LTC) pharmacy services in Southwest Florida. This addition complements their North Port location, enabling better service coverage from Sarasota to Lake Placid to Marco Island.

Guardian Pharmacy of Southwest Florida, established in 2014, has shown significant growth with a 15% annual increase in customer base over the past three years. The Naples location, led by Jay Mandra, PharmD, and Tiffany Fernandez, will enhance service delivery with faster delivery times and improved medication management for LTC communities.

The Naples facility becomes Guardian's eighth pharmacy in Florida, joining locations in Daytona, Jacksonville, Crestview, Orlando, Boca Raton, Tampa, and North Port. Since its founding in 2004, Guardian Pharmacy Services has expanded to 51 pharmacies across 38 states, utilizing a local management business model supported by a centralized Corporate Support Team.